Polaryx Therapeutics is Drug Discovery in United States that focus on neurodegenerative disorders business. Founded in 2014. They cover business area such as developer, small molecule therapeutic, treatment, lysosomal storage disorder, lysosome biogenesis, PPA-dependent up regulation, patient, neurodegenerative disorder.
2014
( 10 years old in 2024 )
Neurodegenerative Disorders
-
140 East Ridgewood Avenue
Suite. 415, South Tower
Paramus, NJ 07652
United States
Private
developersmall molecule therapeutictreatmentlysosomal storage disorderlysosome biogenesisPPA-dependent up regulationpatientneurodegenerative disorder
* We use standard office opening hours in near Polaryx Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Polaryx Therapeutics is Drug Discovery business from United States that founded in 2014 (10 years old in 2024), Polaryx Therapeutics business is focusing on Neurodegenerative Disorders.
Polaryx Therapeutics headquarter office and corporate office address is located in 140 East Ridgewood Avenue Suite. 415, South Tower Paramus, NJ 07652 United States.
Polaryx Therapeutics was founded in United States.
In 2024, Polaryx Therapeutics is currently focus on neurodegenerative disorders sector.
Above is snippet of Google Trends for "neurodegenerative disorders" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Polaryx Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.